Publications of Mathurin Dorel

Lazaro-Navarro, J.; Alcon, C.; Dorel, M.; Alasfar, L.; Bastian, L.; Baldus, C.; Astrahantseff, K.; Yaspo, M.-L.; Montero, J.; Eckert, C.: Inhibiting H3K27 Demethylases Downregulates CREB-CREBBP, Overcoming Resistance in Relapsed Acute Lymphoblastic Leukemia. Cancer Medicine 14 (1), pp. 1 - 7 (2025)

Sultana, Z.; Dorel, M.; Klinger, B.; Sieber, A.; Dunkel, I.; Blüthgen, N.; Schulz, E. G.: Modeling unveils sex differences of signaling networks in mouse embryonic stem cells. Molecular Systems Biology 19 (11), e11510 (2023)

Berlak, M.; Tucker, E.; Dorel, M.; Winkler, A.; McGearey, A.; Rodriguez-Fos, E.; Martins da Costa, B.; Barker, K.; Fyle, E.; Calton, E. et al.; Eising, S.; Ober, K.; Hughes, D.; Koutroumanidou, E.; Carter, P.; Stankunaite, R.; Proszek, P.; Jain, N.; Rosswog, C.; Dorado-Garcia, H.; Molenaar, J. J.; Hubank, M.; Barone, G.; Anderson, J.; Lang, P.; Deubzer, H. E.; Künkele, A.; Fischer, M.; Eggert, A.; Kloft, C.; Henssen, A. G.; Boettcher, M.; Hertwig, F.; Blüthgen, N.; Chesler, L.; Schulte, J. H.: Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells. Molecular Cancer 21, 126 (2022)

Dorel, M.; Balzereit, D.; Kovacsovics, A.; Eckert, C.; Yaspo, M.-L.: Reverse engineering BCP-ALL signaling with large knock-out screens. 35. Jahrestagung der Kind-Philipp-Stiftung für pädiatrisch onkologische Forschung, Wilsede, June 05, 2024 - June 08, 2024. Klinische Pädiatrie 236 (03), Article 203, (2024)